E16 148
Zalmai Hakimi
d
Paul Abrams
a
a
Department of Urology, Bristol Urological Institute, Bristol, UK
b
Department of Urology, Freeman Hospital, Newcastle, UK
c
Department of Urology, Royal Hallamshire Hospital, Shef
fi
eld, UK
d
Astellas Pharma, Leiden, The Netherlands
*Corresponding author. Bristol Urological Institute, Learning and
Research Building, Southmead Hospital, Bristol BS10 5NB, UK.
Tel. +44 117 4147934.
E-mail address:
alan.uren@bui.ac.uk(A.D. Uren).
July 28, 2017
E U R O P E A N U R O L O GY 7 3 ( 2 0 18 ) e 15
–
e 16
e16